Mina Makar highlights AstraZeneca's commitment to advancing heart failure research and innovative therapies, addressing ...

The global cardiovascular devices market, valued at US$ 72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, reaching US$ ...

The global cardiovascular devices market, valued at US$ 72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, reaching ...

Among the general US population, simple and affordable non-invasive liver fibrosis scoring systems may be able to identify individuals at risk for HF.

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiovascular disease remains a leading cause of death and disability worldwide. Heart failure (HF) is ...

Type 2 diabetes is common; it affects one in ten adults internationally and one in five adults aged 65 years or older. It is ...

Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...

Heart failure and cardiomyopathies pose significant global health challenges due to their complex pathophysiological mechanisms and diverse etiologies.

Heart failure (HF) is a disease that leads to approximately 300,000 fatalities annually in Europe and 250,000 deaths each year in the United States. Type 2 Diabetes Mellitus (T2DM) is a significant ...

By Chioma Obinna The Olujimi family is urgently seeking N25 million for a heart surgery for their daughter, Mirabel. The ...

A research team in the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) ...

A Fitbit got a reporter to see his doctor — and ultimately go under the knife. Are wearables the next wave in heart health?